IMPACT Medicom

Precision Medicine in Oncology: Ep.6 Biomarker testing in metastatic colorectal cancer – mismatch repair and beyond

November 26, 2021 IMPACT Medicom
IMPACT Medicom
Precision Medicine in Oncology: Ep.6 Biomarker testing in metastatic colorectal cancer – mismatch repair and beyond
Show Notes

Welcome to episode 6 of IMPACT Medicom’s podcast series on Precision Medicine in Oncology. In this episode Dr. Gonzalez discusses testing methodology, particularly for mismatch repair deficiency, as well as potential emerging biomarkers for metastatic colorectal cancer.

Our Guest:
Dr. Raul Gonzalez is an Associate Professor of Pathology at Harvard Medical School and the Director of Gastrointestinal Pathology at Beth Israel Deaconess Medical Center in Boston, Massachusetts.  Dr. Gonzalez is a surgical pathologist specializing in gastrointestinal pathology. He is the Editor- in-Chief of Pathology Outlines and the Reviews Editor for Histopathology. He also serves as the Vice Chair for the College of American Pathologists Surgical Pathology Committee and the Website Committee Chair for the Hans Popper Hepatopathology Society.

This podcast episode was sponsored by Merck Canada.

If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com